1. O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome
Fengxue Zhang, Kaihong Su, Xiaoyong Yang, Damon B. Bowe, Andrew J. Paterson, Jeffrey E. Kudlow 
Cell 
Volume 115, Issue 6, Pages (December 2003)
DOI: /S (03)

2. Figure 1
Generation of GST-SpX from GST-Sp1 (degradation) by Active NE Is Inhibited by GST-OGT
(A) Recombinant GST-Sp1 is degraded by activated nuclear extract from NRK cells treated with forskolin and glucose starvation and not degraded by extract from glucosamine-treated cells.
(B) GST-Sp1 degradation, assessed by GST Western blot, is inhibited by GST-OGT but not its truncation mutants produced by vaccinia virus. Nucleotide-sugars (5 μM) were added as indicated.
(C) GST-Sp1 degradation is inhibited by E. coli-produced GST-OGT.
(D) GST-Sp1 degradation is inhibited by His-tagged OGT produced with vaccinia virus.
Cell  , DOI: ( /S (03) )

3. Figure 2
O-GlcNAc State of Sp1 Has No Effect on Its Proteasomal Degradation
The GST-Sp1 was analyzed by Western blot with the indicated antibodies.
(A) Anti-GST blot shows equal loading of GST-Sp1.
(B) RL-2 blot shows O-GlcNAc state of GST-Sp1.
(C) The indicated preparations of Sp1 were added to activated nuclear extract. The appearance of GST-SpX, the first step in Sp1 degradation, was independent of the starting Sp1 O-GlcNAc level.
(D) Degradation of GST-Sp1 with different O-glycosylation levels can all be inhibited by OGT.
Cell  , DOI: ( /S (03) )

4. Figure 3
The Proteasome Chymotrypsin-like Peptidase Activity Is Inhibited by OGT Plus UDP-GlcNAc
The fluorescence from the cleavage of suc-LLVY-AMC peptide was measured by fluorometry. The graphs show relative fluorescence with 100% occurring in the absence of inhibitor.
(A) Chymotrypsin-like peptidase activity in active NRK nuclear extract was inhibited by various proteasome inhibitors (50 μM).
(B) Chymotrypsin-like peptidase activity in the active NE was inhibited by GST-OGT and epoxomicin but not inactive OGT truncation mutants.
(C) Commassie blue staining of SDS-PAGE 26S proteasome proteins. The proteasomes were purified to the indicated degree. The HP-26S proteasomes were >95% pure.
(D) Chymotrypsin-like peptidase activity of 65% pure 26S proteasomes was inhibited by catalytically active GST-OGT.
(E) Chymotrypsin-like peptidase activity of 65% pure 26S proteasomes required 5 μM UDP-GlcNAc for inhibition by GST-OGT.
(F) Chymotrypsin-like peptidase activity of 20S proteasome core particles was not affected by GST-OGT.
Cell  , DOI: ( /S (03) )

5. Figure 4
The Proteasome Trypsin-like Peptidase Activity, Measured by Fluorescence from the Cleavage of boc-LSTR-AMC, Was Not Affected by OGT Plus UDP-GlcNAc Treatment
(A) Trypsin-like peptidase activity in the active nuclear extract was not affected by GST-OGT.
(B) Trypsin-like peptidase activity of the 26S proteasomes was not affected by GST-OGT.
(C) Trypsin-like peptidase activity of the 20S proteasomes was not affected by GST-OGT.
Cell  , DOI: ( /S (03) )

6. Figure 5
The ATPase activity of the 26S proteasome was inhibited by OGT
(A) Average hydrophobicity score of the proteasome peptide substrates (Sweet and Eisenberg, 1983).
(B) The degradation of chymotryptic fluorogenic peptide substrate Z-GGL-AMC by 65% pure 26S proteasome was not affected by OGT treatment.
(C) The degradation of chymotryptic fluorogenic peptide substrate Z-GGL-AMC by the active nuclear extract was not affected by OGT treatment.
(D) The ATPase activity of 65% pure 26S proteasomes was inhibited by OGT treatment.
(E) Chymotrypsin-like peptidase activity of >95% pure 26S proteasomes was inhibited by GST-OGT.
(F) The ATPase activity of >95% pure 26S proteasomes was inhibited by OGT treatment.
Cell  , DOI: ( /S (03) )

7. Figure 6 Physiologic Role of O-GlcNAc in Proteasome Function
(A–C) AMP-PNP inhibited the degradation of LLVY (A), but not that of GGL (B) nor LSTR (C). The fluorescence signal was measured as before.
(D) Degradation versus synthesis of GFP-degron in cells cotransfected with OGT siRNA. A net increase in GFP fluorescence was observed in cells cotransfected with OGT siRNA compared to cells cotransfected with a scrambled sequence. When GFP was tagged for proteasome degradation, a net decrease in GFP-degron fluorescence was observed in the OGT siRNA over the scramble transfectants.
(E) The degradation of chymotryptic peptide substrate suc-LLVY-AMC by glucosamine inactivated NE was stimulated by GST-O-GlcNAcase. Ten microliters of inactive nuclear extract was pretreated as indicated. After the GST-O-GlcNAcase on beads was removed, the supernatant was treated with or without 50 μM of the indicated proteasome inhibitor and the peptidase activity was measured.
(F) Chymotryptic activity of purified proteasomes, inhibited by OGT, can be recovered with O-GlcNAcase. The recovered activity was 35% greater than the starting material.
Cell  , DOI: ( /S (03) )

8. Figure 7
Subunits of Pure Proteasomes Including Rpt2 Were Modified by O-GlcNAc
(A) Untreated proteasome proteins were resolved by two-dimensional gel electrophoresis and then Western blotted with RL-2. All detectable spots are shown.
(B) Proteasomes were treated with OGT and confirmed inactivated (LLVY assay) prior to two-dimensional gel electrophoresis and RL-2 blot. The filled arrow indicates the putative position of Rpt2.
(C) The blot in (B) was stripped and reprobed with an Rpt2 antibody. Rpt2 appeared as a close doublet (filled arrow) at the putative position while the other spots vanished (hollow arrow). Shown here is the same area of the gel shown in (A) and (B).
(D) Partially purified 26S proteasomes were labeled by OGT, and the protein was resolved by SDS-PAGE and blotted with RL-2. No proteasomes were loaded on lanes 3 and 4.
(E) Anti-Rpt2 blot of the stripped membrane from (D).
(F) Rpt2 was immunoprecipated from the cell lysates of forskolin- or glucosamine-treatedNRK cells, and the immunoprecipitate was subjected to SDS-PAGE and Western blotting with RL-2.
(G) The Western blot, probed for Rpt2, indicates equal amounts of Rpt2 in the lysate.
(H) Recombinant GST-Rpt2 is a substrate for OGT in vitro. Recombinant Rpt2 was exposed to OGT plus UDP-GlcNAc, then analyzed by Western blot with RL-2.
Cell  , DOI: ( /S (03) )